This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Eligibility criteria from pharmaceutical randomised controlled trials of idiopathic pulmonary fibrosis: a registry-based study
European Respiratory Journal · 2023
Latest funding
- $914,175
Improving Canadian Lung Cancer Screening Efficiency with a Computed Tomography Risk Classifier
CIHR · 2022 · Principal investigator
- $1,086,300
Air pollution, climate and COPD: acute and long-term impacts in Canadian populations
CIHR · 2020 · Co-investigator
1 publications.
Eligibility criteria from pharmaceutical randomised controlled trials of idiopathic pulmonary fibrosis: a registry-based study
Khor YH, Schulte M, Johannson KA, Marcoux V, Fisher JH, Assayag D, Manganas H, Khalil N, Kolb M, Ryerson CJ
Improving Canadian Lung Cancer Screening Efficiency with a Computed Tomography Risk Classifier
Principal investigators: Smith, Benjamin M; Kirby, Miranda A; Sadatsafavi, Mohsen
Keywords: Airways; Computed Tomography; Lung Cancer; Screening
Air pollution, climate and COPD: acute and long-term impacts in Canadian populations
Principal investigators: Bourbeau, Jean; Brook, Jeffrey R; Smith, Benjamin M
Keywords: Air Pollution; Climate Change; Copd; Exacerbations; Extreme Weather
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medicine
- Medicine/Respirology
- Pediatrics
- Other
Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.